Epithelial-microbial diplomacy: escalating border tensions drive inflammation in inflammatory bowel disease

다국어 초록 (Multilingual Abstract)

Inflammatory bowel diseases (IBD) are chronic conditions of the gastrointestinal tract-the main site of host-microbial interaction in the body. Development of IBD is not due to a single event but rather is a multifactorial process where a patient’s genetic background, behavioral habits, and environmental exposures contribute to disease pathogenesis. IBD patients exhibit alterations to gut bacterial populations “dysbiosis” due to the inflammatory microenvironment, however whether this alteration of the gut microbiota precedes inflammation has not been confirmed. Emerging evidence has highlighted the important role of gut microbes in developing measured immune responses and modulating other host responses such as metabolism. Much of the work on the gut microbiota has been correlative and there is an increasing need to understand the intimate relationship between host and microbe. In this review, we highlight how commensal and pathogenic bacteria interact with host intestinal epithelial cells and explore how altered microenvironments impact these connections. (Intest Res 2019;17:177-191)

참고문헌 (Reference)

• 1 Walker AW, "pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon" 71 : 3692-3700, 2005
• 2 Bolick DT, "Zinc deficiency alters host response and pathogen virulence in a mouse model of enteroaggregative Escherichia coli-induced diarrhea" 5 : 618-627, 2014
• 3 Ng SC, "Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century : a systematic review of population-based studies" 390 : 2769-2778, 2018
• 4 Maier E, "Understanding how commensal obligate anaerobic bacteria regulate immune functions in the large intestine" 7 : 45-73, 2014
• 5 Zeng J, "Translocation of Enterococcus faecalis strains across a monolayer of polarized human enterocyte-like T84 cells" 42 : 1149-1154, 2004
• 6 Wu C, "Transient activation of mucosal effector immune responses by resident intestinal bacteria in normal hosts is regulated by interleukin-10 signalling" 148 : 304-314, 2016
• 7 Cario E, "Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function" 132 : 1359-1374, 2007
• 8 Baughn AD, "The strict anaerobe Bacteroides fragilis grows in and benefits from nanomolar concentrations of oxygen" 427 : 441-444, 2004
• 9 Robinson LS, "The sialate O-acetylesterase EstA from gut Bacteroidetes species enables sialidase-mediated cross-species foraging of 9-O-acetylated sialoglycans" 292 : 11861-11872, 2017
• 10 Brown EM, "The role of the immune system in governing host-microbe interactions in the intestine" 14 : 660-667, 2013
• 11 Alam A, "The microenvironment of injured murine gut elicits a local pro-restitutive microbiota" 1 : 15021-, 2016
• 12 Karlsson CL, "The microbiota of the gut in preschool children with normal and excessive body weight" 20 : 2257-2261, 2012
• 13 Lopez CA, "The impact of dietary transition metals on host-bacterial interactions" 23 : 737-748, 2018
• 14 Davenport ER, "The human microbiome in evolution" 15 : 127-, 2017
• 15 van Passel MW, "The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes" 6 : e16876-, 2011
• 16 Marchiando AM, "The epithelial barrier is maintained by in vivo tight junction expansion during pathologic intestinal epithelial shedding" 140 : 1208-1218, 2011
• 17 Rolhion N, "The endoplasmic reticulum stress response chaperone : Gp96, a host receptor for Crohn disease-associated adherent-invasive Escherichia coli" 2 : 115-119, 2011
• 18 Fiorucci S, "The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver" 131 : 259-271, 2006
• 19 Arthur JC, "The complex interplay between inflammation, the microbiota and colorectal cancer" 4 : 253-258, 2013
• 20 Omenetti S, "The Treg/Th17 axis : a dynamic balance regulated by the gut microbiome" 6 : 639-, 2015
• 21 Sadaghian Sadabad M, "The ATG16L1-T300A allele impairs clearance of pathosymbionts in the inflamed ileal mucosa of Crohn’s disease patients" 64 : 1546-1552, 2015
• 22 Atarashi K, "Th17 cell induction by adhesion of microbes to intestinal epithelial cells" 163 : 367-380, 2015
• 23 Ocvirk S, "Surface-associated lipoproteins link Enterococcus faecalis virulence to colitogenic activity in IL-10-deficient mice independent of their expression levels" 11 : e1004911-, 2015
• 24 Shen X, "Supplementation of p40, a Lactobacillus rhamnosus GG-derived protein, in early life promotes epidermal growth factor receptor-dependent intestinal development and long-term health outcomes" 11 : 1316-1328, 2018
• 25 Ermund A, "Studies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer’s patches" 305 : G341-G347, 2013
• 26 Yan F, "Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth" 132 : 562-575, 2007
• 27 Talbot C, "Segregation of Na/H exchanger-3 and Cl/HCO3 exchanger SLC26A3(DRA)in rodent cecum and colon" 299 : G358-G367, 2010
• 28 Goto Y, "Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation" 40 : 594-607, 2014
• 29 Zhang YG, "Salmonella infection upregulates the leaky protein claudin-2 in intestinal epithelial cells" 8 : e58606-, 2013
• 30 Sender R, "Revised estimates for the number of human and bacteria cells in the body" 14 : e1002533-, 2016
• 31 Faber F, "Respiration of microbiota-derived 1, 2-propanediol drives Salmonella expansion during colitis" 13 : e1006129-, 2017
• 32 Charlet R, "Remodeling of the Candida glabrata cell wall in the gastrointestinal tract affects the gut microbiota and the immune response" 8 : 3316-, 2018
• 33 Vinderola CG, "Relationship between interaction sites in the gut, hydrophobicity, mucosal immunomodulating capacities and cell wall protein profiles in indigenous and exogenous bacteria" 96 : 230-243, 2004
• 34 Ulluwishewa D, "Regulation of tight junction permeability by intestinal bacteria and dietary components" 141 : 769-776, 2011
• 35 Maslowski KM, "Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43" 461 : 1282-1286, 2009
• 36 Alam A, "Redox signaling regulates commensal-mediated mucosal homeostasis and restitution and requires formyl peptide receptor 1" 7 : 645-655, 2014
• 37 Deriu E, "Probiotic bacteria reduce Salmonella typhimurium intestinal colonization by competing for iron" 14 : 26-37, 2013
• 38 Dahlhamer JM, "Prevalence of inflammatory bowel disease among adults aged ≥18 years-United States, 2015" 65 : 1166-1169, 2016
• 39 Mahendran V, "Prevalence of Campylobacter species in adult Crohn’s disease and the preferential colonization sites of Campylobacter species in the human intestine" 6 : e25417-, 2011
• 40 Zhu W, "Precision editing of the gut microbiota ameliorates colitis" 553 : 208-211, 2018
• 41 Mathias A, "Potentiation of polarized intestinal Caco-2 cell responsiveness to probiotics complexed with secretory IgA" 285 : 33906-33913, 2010
• 42 Ottman N, "Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function" 12 : e0173004-, 2017
• 43 Rajilić-Stojanović M, "Phylogenetic analysis of dysbiosis in ulcerative colitis during remission" 19 : 481-488, 2013
• 44 Haberman Y, "Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature" 124 : 3617-3633, 2014
• 45 Nielsen HL, "Oral and fecal Cam pylobacter concisus strains perturb barrier function by apoptosis induction in HT-29/B6 intestinal epithelial cells" 6 : e23858-, 2011
• 46 Johansson ME, "Normalization of host intestinal mucus layers requires long-term microbial colonization" 18 : 582-592, 2015
• 47 Chan JL, "Non-toxigenic Bacteroides fragilis(NTBF)administration reduces bacteria-driven chronic colitis and tumor development independent of polysaccharide A" 12 : 164-177, 2019
• 48 Petnicki-Ocwieja T, "Nod2 is required for the regulation of commensal microbiota in the intestine" 106 : 15813-15818, 2009
• 49 Rehman A, "Nod2 is essential for temporal development of intestinal microbial communities" 60 : 1354-1362, 2011
• 50 Lopez-Siles M, "Mucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease" 81 : 7582-7592, 2015
• 51 Png CW, "Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria" 105 : 2420-2428, 2010
• 52 Frank DN, "Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases" 104 : 13780-13785, 2007
• 53 Banla IL, "Modulators of Enterococcus faecalis cell envelope integrity and antimicrobial resistance influence stable colonization of the mammalian gastrointestinal tract" 86 : e00381-17-, 2017
• 54 Ng KM, "Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens" 502 : 96-99, 2013
• 55 Wu W, "Microbiota metabolite short-chain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43" 10 : 946-956, 2017
• 56 이나은, "Microbiota in T-cell homeostasis and inflammatory diseases" 생화학분자생물학회 49 : 1-10, 2017
• 57 Hughes ER, "Microbial respiration and formate oxidation as metabolic signatures of inflammation-associated dysbiosis" 21 : 208-219, 2017
• 58 Belzer C, "Microbial metabolic networks at the mucus layer lead to diet-independent butyrate and vitamin B(12)production by intestinal symbionts" 85 : e00770-, 2017
• 59 Breyner NM, "Microbial anti-inflammatory molecule(MAM)from Faecalibacterium prausnitzii shows a protective effect on DNBS and DSS-induced colitis model in mice through inhibition of NF-kappaB pathway" 8 : 114-, 2017
• 60 Chassaing B, "Mice harboring pathobiont-free microbiota do not develop intestinal inflammation that normally results from an innate immune deficiency" 13 : e0195310-, 2018
• 61 Anderson CA, "Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47" 43 : 246-252, 2011
• 62 Watson AJ, "Mechanisms of epithelial cell shedding in the mammalian intestine and maintenance of barrier function" 1165 : 135-142, 2009
• 63 Sokol H, "Low counts of Faecalibacterium prausnitzii in colitis microbiota" 15 : 1183-1189, 2009
• 64 Maier E, "Live Faecalibacterium prausnitzii does not enhance epithelial barrier integrity in an apical anaerobic co-culture model of the large intestine" 9 : 1349-, 2017
• 65 He X, "Lactobacillus rhamnosus GG supernatant enhance neonatal resistance to systemic Escherichia coli K1 infection by accelerating development of intestinal defense" 7 : 43305-, 2017
• 66 Van Tassell ML, "Lactobacillus adhesion to mucus" 3 : 613-636, 2011
• 67 Knoop KA, "Isolated lymphoid follicles are dynamic reservoirs for the induction of intestinal IgA" 3 : 84-, 2012
• 68 Jia W, "Is the abundance of Faecalibacterium prausnitzii relevant to Crohn’s disease" 310 : 138-144, 2010
• 69 Thiennimitr P, "Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota" 108 : 17480-17485, 2011
• 70 Pott J, "Intestinal epithelial cell autophagy is required to protect against TNF-induced apoptosis during chronic colitis in mice" 23 : 191-202, 2018
• 71 Madsen KL, "Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora" 5 : 262-270, 1999
• 72 Tchaptchet S, "Inflammation-induced acid tolerance genes gadAB in luminal commensal Escherichia coli attenuate experimental colitis" 81 : 3662-3671, 2013
• 73 Ivanov II, "Induction of intestinal Th17 cells by segmented filamentous bacteria" 139 : 485-498, 2009
• 74 Round JL, "Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota" 107 : 12204-12209, 2010
• 75 Wlodarska M, "Indoleacrylic acid produced by commensal peptostreptococcus species suppresses inflammation" 22 : 25-37, 2017
• 76 Belenguer A, "Impact of pH on lactate formation and utilization by human fecal microbial communities" 73 : 6526-6533, 2007
• 77 Hoffmann M, "Impact of a probiotic Enterococcus faecalis in a gnotobiotic mouse model of experimental colitis" 55 : 703-713, 2011
• 78 Palm NW, "Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease" 158 : 1000-1010, 2014
• 79 Hooper LV, "Immune adaptations that maintain homeostasis with the intestinal microbiota" 10 : 159-169, 2010
• 80 Tan TG, "Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice" 113 : E8141-E8150, 2016
• 81 Quévrain E, "Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease" 65 : 415-425, 2016
• 82 Tsai PY, "IL-22 upregulates epithelial claudin-2 to drive diarrhea and enteric pathogen clearance" 21 : 671-681, 2017
• 83 McCole DF, "IBD candidate genes and intestinal barrier regulation" 20 : 1829-1849, 2014
• 84 Bollinger RR, "Human secretory immunoglobulin A may contribute to biofilm formation in the gut" 109 : 580-587, 2003
• 85 Lupp C, "Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae" 2 : 204-, 2007
• 86 Berry D, "Host-compound foraging by intestinal microbiota revealed by single-cell stable isotope probing" 110 : 4720-4725, 2013
• 87 Bäckhed F, "Host-bacterial mutualism in the human intestine" 307 : 1915-1920, 2005
• 88 Man SM, "Host attachment, invasion, and stimulation of proinflammatory cytokines by Campylobacter concisus and other non-Campylobacter jejuni Campylobacter species" 202 : 1855-1865, 2010
• 89 Roulis M, "Host and microbiota interactions are critical for development of murine Crohn’s-like ileitis" 9 : 787-797, 2016
• 90 Donaldson GP, "Gut microbiota utilize immunoglobulin A for mucosal colonization" 360 : 795-800, 2018
• 91 Franzosa EA, "Gut microbiome structure and metabolic activity in inflammatory bowel disease" 4 : 293-305, 2019
• 92 Vazeille E, "GipA factor supports colonization of Peyer’s patches by Crohn’s disease-associated Escherichia coli" 22 : 68-81, 2016
• 93 Franke A, "Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci" 42 : 1118-1125, 2010
• 94 McGovern DP, "Genome-wide association identifies multiple ulcerative colitis susceptibility loci" 42 : 332-337, 2010
• 95 Barrett JC, "Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease" 40 : 955-962, 2008
• 96 Zeng J, "Gelatinase is important for translocation of Enterococcus faecalis across polarized human enterocyte-like T84 cells" 73 : 1606-1612, 2005
• 97 Koh A, "From dietary fiber to host physiology : short-chain fatty acids as key bacterial metabolites" 165 : 1332-1345, 2016
• 98 Vernia P, "Fecal lactate and ulcerative colitis" 95 : 1564-1568, 1988
• 99 Sokol H, "Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients" 105 : 16731-16736, 2008
• 100 Wells CL, "Evidence for the translocation of Enterococcus faecalis across the mouse intestinal tract" 162 : 82-90, 1990
• 101 Pham TA, "Epithelial IL-22RA1-mediated fucosylation promotes intestinal colonization resistance to an opportunistic pathogen" 16 : 504-516, 2014
• 102 Arumugam M, "Enterotypes of the human gut microbiome" 473 : 174-180, 2011
• 103 Bertin Y, "Enterohaemorrhagic Escherichia coli gains a competitive advantage by using ethanolamine as a nitrogen source in the bovine intestinal content" 13 : 365-377, 2011
• 104 Medani M, "Emerging role of hydrogen sulfide in colonic physiology and pathophysiology" 17 : 1620-1625, 2011
• 105 Levy M, "Dysbiosis and the immune system" 17 : 219-232, 2017
• 106 Devkota S, "Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/-mice" 487 : 104-108, 2012
• 107 Mukhopadhya I, "Detection of Campylobacter concisus and other Campylobacter species in colonic biopsies from adults with ulcerative colitis" 6 : e21490-, 2011
• 108 Zhang L, "Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn’s disease" 47 : 453-455, 2009
• 109 Rivera-Chávez F, "Depletion of butyrate-producing clostridia from the gut microbiota drives an aerobic luminal expansion of Salmonella" 19 : 443-454, 2016
• 110 Chairatana P, "Defensins, lectins, mucins, and secretory immunoglobulin A : microbe-binding biomolecules that contribute to mucosal immunity in the human gut" 52 : 45-56, 2017
• 111 Blander JM, "Death in the intestinal epithelium-basic biology and implications for inflammatory bowel disease" 283 : 2720-2730, 2016
• 112 Centers for Disease Control and Prevention, "Data and statistics: inflammatory bowel disease prevalence (IBD) in the United States"
• 113 Bazett M, "Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome" 26 : 222-234, 2015
• 114 Lopez-Siles M, "Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth" 78 : 420-428, 2012
• 115 Scanlan PD, "Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn’s disease" 44 : 3980-3988, 2006
• 116 Everard A, "Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity" 110 : 9066-9071, 2013
• 117 Albenberg L, "Correlation between intraluminal oxygen gradient and radial partitioning of intestinal microbiota" 147 : 1055-1063, 2014
• 118 Knights D, "Complex host genetics influence the microbiome in inflammatory bowel disease" 6 : 107-, 2014
• 119 Litvak Y, "Colonocyte metabolism shapes the gut microbiota" 362 : eaat9076-, 2018
• 120 Raisch J, "Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation" 20 : 6560-6572, 2014
• 121 Patwa LG, "Chronic intestinal inflammation induces stress-response genes in commensal Escherichia coli" 141 : 1842-1851, 2011
• 122 Blachier F, "Changes in the luminal environment of the colonic epithelial cells and physiopathological consequences" 187 : 476-486, 2017
• 123 Verma R, "Cell surface polysaccharides of Bifidobacterium bifidum induce the generation of Foxp3(+) regulatory T cells" 3 : eaat6975-, 2018
• 124 Clayton JB, "Captivity humanizes the primate microbiome" 113 : 10376-10381, 2016
• 125 Tajkarimi M, "CRISPR-Cas systems in Bacteroides fragilis, an important pathobiont in the human gut microbiome" 8 : 2234-, 2017
• 126 Van den Abbeele P, "Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model" 7 : 949-961, 2013
• 127 Thibault R, "Butyrate utilization by the colonic mucosa in inflammatory bowel diseases : a transport deficiency" 16 : 684-695, 2010
• 128 Gaudier E, "Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose" 287 : G1168-G1174, 2004
• 129 Swidsinski A, "Biostructure of fecal microbiota in healthy subjects and patients with chronic idiopathic diarrhea" 135 : 568-579, 2008
• 130 Vora P, "Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells" 173 : 5398-5405, 2004
• 131 Ramanan D, "Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal Bacteroides vulgatus" 41 : 311-324, 2014
• 132 Norkina O, "Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine" 72 : 6040-6049, 2004
• 133 Cougnoux A, "Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype" 63 : 1932-1942, 2014
• 134 Hugot JP, "Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease" 411 : 599-603, 2001
• 135 Cao Y, "Association between Faecalibacterium prausnitzii reduction and inflammatory bowel disease : a meta-analysis and systematic review of the literature" 2014 : 872725-, 2014
• 136 Khan KJ, "Antibiotic therapy in inflammatory bowel disease : a systematic review and meta-analysis" 106 : 661-673, 2011
• 137 Turnbaugh PJ, "An obesity-associated gut microbiome with increased capacity for energy harvest" 444 : 1027-1031, 2006
• 138 Shin NR, "An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice" 63 : 727-735, 2014
• 139 Mazmanian SK, "An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system" 122 : 107-118, 2005
• 140 Wang Y, "An LGG-derived protein promotes IgA production through upregulation of APRIL expression in intestinal epithelial cells" 10 : 373-384, 2017
• 141 Sano T, "An IL-23R/IL-22 circuit regulates epithelial serum amyloid a to promote local effector Th17 responses" 163 : 381-393, 2015
• 142 Mondot S, "Altered gut microbiota composition in immune-impaired Nod2(-/-)mice" 61 : 634-635, 2012
• 143 Lopez-Siles M, "Alterations in the abundance and co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the colonic mucosa of inflammatory bowel disease subjects" 8 : 281-, 2018
• 144 Runkel NS, "Alterations in rat intestinal transit by morphine promote bacterial translocation" 38 : 1530-1536, 1993
• 145 Chaithanya Chelakkot, "Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions" 생화학분자생물학회 50 : 1-11, 2018
• 146 Derrien M, "Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium" 54 : 1469-1476, 2004
• 147 Dao MC, "Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity : relationship with gut microbiome richness and ecology" 65 : 426-436, 2016
• 148 Reunanen J, "Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of the epithelial cell layer" 81 : 3655-3662, 2015
• 149 Gerardo SH, "Adherence of Bilophila wadsworthia to cultured human embryonic intestinal cells" 4 : 19-27, 1998
• 150 Ouwerkerk JP, "Adaptation of Akkermansia muciniphila to the oxic-anoxic interface of the mucus layer" 82 : 6983-6993, 2016
• 151 Swidsinski A, "Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum" 60 : 34-40, 2011
• 152 Rolhion N, "Abnormally expressed ER stress response chaperone Gp96 in CD favours adherent-invasive Escherichia coli invasion" 59 : 1355-1362, 2010
• 153 Bretin A, "AIEC infection triggers modification of gut microbiota composition in genetically predisposed mice, contributing to intestinal inflammation" 8 : 12301-, 2018
• 154 Chow J, "A pathobiont of the microbiota balances host colonization and intestinal inflammation" 7 : 265-276, 2010
• 155 Mazmanian SK, "A microbial symbiosis factor prevents intestinal inflammatory disease" 453 : 620-625, 2008
• 156 Price AE, "A map of Toll-like receptor expression in the intestinal epithelium reveals distinct spatial, cell type-specific, and temporal patterns" 49 : 560-575, 2018
• 157 Gomes-Neto JC, "A gut pathobiont synergizes with the microbiota to instigate inflammatory disease marked by immunoreactivity against other symbionts but not itself" 7 : 17707-, 2017
• 158 Xu J, "A genomic view of the human-Bacteroides thetaiotaomicron symbiosis" 299 : 2074-2076, 2003